What is Sight Sciences, Inc.'s earnings per share (EPS)?

Sight Sciences, Inc. (SGHT) reported diluted earnings per share of $-0.74 for fiscal year 2025. This represents a 28.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sight Sciences, Inc. Financials

SGHT

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Sight Sciences, Inc. (SGHT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 36/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Sight Sciences, Inc. has an operating margin of -47.9%, meaning the company retains $-48 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -63.3% the prior year.

Growth

Sight Sciences, Inc.'s revenue declined 3.1% year-over-year, from $79.9M to $77.4M. This contraction results in a growth score of 28/100.

Leverage

Sight Sciences, Inc. carries a low D/E ratio of 0.63, meaning only $0.63 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 89/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 10.22, Sight Sciences, Inc. holds $10.22 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

While Sight Sciences, Inc. generated -$29.7M in operating cash flow, capex of $224K consumed most of it, leaving -$29.9M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Sight Sciences, Inc. generates a -60.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -58.9% the prior year.

Piotroski F-Score Neutral

5/9

Sight Sciences, Inc. passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality

0.77x

For every $1 of reported earnings, Sight Sciences, Inc. generates $0.77 in operating cash flow (-$29.7M OCF vs -$38.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-7.2x

Sight Sciences, Inc. earns $-7.2 in operating income for every $1 of interest expense (-$37.1M vs $5.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$77.4M

YoY-3.1%

5Y CAGR+22.9%

Sight Sciences, Inc. generated $77.4M in revenue in fiscal year 2025. This represents a decrease of 3.1% from the prior year.

EBITDA

-$36.6M

YoY+26.5%

Sight Sciences, Inc.'s EBITDA was -$36.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 26.5% from the prior year.

Net Income

-$38.4M

YoY+25.4%

Sight Sciences, Inc. reported -$38.4M in net income in fiscal year 2025. This represents an increase of 25.4% from the prior year.

EPS (Diluted)

$-0.74

YoY+28.2%

Sight Sciences, Inc. earned $-0.74 per diluted share (EPS) in fiscal year 2025. This represents an increase of 28.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$29.9M

YoY-31.6%

Sight Sciences, Inc. generated -$29.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 31.6% from the prior year.

Cash & Debt

$92.0M

YoY-23.6%

5Y CAGR+8.4%

Sight Sciences, Inc. held $92.0M in cash against $40.3M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

53M

YoY+5.0%

Sight Sciences, Inc. had 53M shares outstanding in fiscal year 2025. This represents an increase of 5.0% from the prior year.

Margins & Returns

Gross Margin

86.2%

YoY+0.7pp

5Y CAGR+19.5pp

Sight Sciences, Inc.'s gross margin was 86.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.7 percentage points from the prior year.

Operating Margin

-47.9%

YoY+15.3pp

5Y CAGR+68.5pp

Sight Sciences, Inc.'s operating margin was -47.9% in fiscal year 2025, reflecting core business profitability. This is up 15.3 percentage points from the prior year.

Net Margin

-49.7%

YoY+14.8pp

5Y CAGR+75.9pp

Sight Sciences, Inc.'s net profit margin was -49.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 14.8 percentage points from the prior year.

Return on Equity

-60.1%

YoY-1.2pp

Sight Sciences, Inc.'s ROE was -60.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$14.6M

YoY-18.8%

5Y CAGR+10.5%

Sight Sciences, Inc. invested $14.6M in research and development in fiscal year 2025. This represents a decrease of 18.8% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$224K

YoY-41.8%

5Y CAGR-25.1%

Sight Sciences, Inc. invested $224K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 41.8% from the prior year.

SGHT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$77.4M-3.1%	$79.9M-1.5%	$81.1M+13.6%	$71.3M+45.7%	$49.0M+77.1%	$27.6M
Cost of Revenue	$10.7M-7.6%	$11.6M-2.5%	$11.9M-3.9%	$12.4M+43.6%	$8.6M-6.5%	$9.2M
Gross Profit	$66.7M-2.4%	$68.3M-1.3%	$69.2M+17.3%	$59.0M+46.2%	$40.3M+118.9%	$18.4M
R&D Expenses	$14.6M-18.8%	$18.0M+2.5%	$17.6M-23.2%	$22.9M+46.2%	$15.6M+76.2%	$8.9M
SG&A Expenses	$89.2M-11.6%	$100.8M-7.4%	$108.9M-9.3%	$120.1M+57.6%	$76.2M+82.5%	$41.7M
Operating Income	-$37.1M+26.6%	-$50.5M+11.8%	-$57.3M+31.8%	-$84.0M-63.1%	-$51.5M-59.9%	-$32.2M
Interest Expense	$5.1M+10.3%	$4.7M-13.8%	$5.4M+21.1%	$4.5M+2.3%	$4.4M+81.7%	$2.4M
Income Tax	$10K-95.8%	$236K+114.5%	$110K+134.0%	$47K-75.0%	$188K+208.2%	$61K
Net Income	-$38.4M+25.4%	-$51.5M+7.3%	-$55.5M+35.6%	-$86.2M-37.0%	-$63.0M-81.5%	-$34.7M
EPS (Diluted)	$-0.74+28.2%	$-1.03+9.6%	$-1.14+36.7%	$-1.80+23.7%	$-2.36	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$20.4M+2.4%	$19.9M+1.7%	$19.6M+11.7%	$17.5M-8.2%	$19.1M-5.4%	$20.2M-5.7%	$21.4M+10.9%	$19.3M
Cost of Revenue	$2.6M-4.1%	$2.7M-9.0%	$3.0M+23.3%	$2.4M-3.9%	$2.5M-22.7%	$3.3M+7.4%	$3.0M+8.3%	$2.8M
Gross Profit	$17.8M+3.4%	$17.2M+3.7%	$16.6M+9.9%	$15.1M-8.9%	$16.6M-2.0%	$16.9M-7.8%	$18.3M+11.4%	$16.5M
R&D Expenses	$2.4M-27.3%	$3.4M-23.6%	$4.4M-1.0%	$4.4M+3.2%	$4.3M-9.5%	$4.7M+10.0%	$4.3M-6.9%	$4.6M
SG&A Expenses	$19.0M-12.6%	$21.8M-8.9%	$23.9M-2.7%	$24.5M+1.3%	$24.2M+3.5%	$23.4M-12.3%	$26.7M+0.5%	$26.6M
Operating Income	-$3.7M+53.6%	-$7.9M+32.2%	-$11.7M+15.8%	-$13.9M-16.2%	-$11.9M-6.2%	-$11.2M+11.2%	-$12.7M+14.1%	-$14.7M
Interest Expense	$1.3M-1.3%	$1.3M+1.7%	$1.3M+1.7%	$1.3M+8.7%	$1.2M+1.0%	$1.2M+0.5%	$1.1M-4.9%	$1.2M
Income Tax	$8K+110.1%	-$79K-297.5%	$40K-2.4%	$41K+7.9%	$38K-77.1%	$166K+1006.7%	$15K-11.8%	$17K
Net Income	-$4.2M+49.1%	-$8.2M+31.6%	-$11.9M+15.6%	-$14.2M-19.5%	-$11.8M-7.0%	-$11.1M+10.2%	-$12.3M+24.2%	-$16.3M
EPS (Diluted)	N/A	$-0.16+30.4%	$-0.23+17.9%	$-0.28	N/A	$-0.22+12.0%	$-0.25+24.2%	$-0.33

SGHT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$115.3M-19.3%	$142.8M-14.3%	$166.7M-21.8%	$213.1M-24.0%	$280.2M+284.8%	$72.8M
Current Assets	$112.7M-19.3%	$139.8M-14.2%	$162.9M-22.3%	$209.7M-24.3%	$277.0M+292.2%	$70.6M
Cash & Equivalents	$92.0M-23.6%	$120.4M-12.9%	$138.1M-25.3%	$185.0M-29.0%	$260.7M+323.8%	$61.5M
Inventory	$7.8M+22.8%	$6.3M-19.4%	$7.8M+28.4%	$6.1M+75.9%	$3.5M+33.8%	$2.6M
Accounts Receivable	$9.7M-9.7%	$10.8M-24.5%	$14.3M-5.7%	$15.1M+73.9%	$8.7M+62.4%	$5.4M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$51.4M-7.2%	$55.3M+19.1%	$46.4M-12.4%	$53.0M+10.2%	$48.1M-70.3%	$161.7M
Current Liabilities	$11.0M-28.7%	$15.5M+26.2%	$12.3M-31.2%	$17.8M+31.9%	$13.5M+45.0%	$9.3M
Long-Term Debt	$40.3M+2.4%	$39.4M+24.1%	$31.7M-4.8%	$33.3M+2.0%	$32.7M+2.2%	$32.0M
Total Equity	$63.9M-26.9%	$87.5M-27.2%	$120.2M-24.9%	$160.1M-31.0%	$232.1M+361.2%	-$88.8M
Retained Earnings	-$384.7M-11.1%	-$346.3M-17.5%	-$294.8M-23.2%	-$239.2M-56.4%	-$153.0M-69.9%	-$90.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$115.3M-0.8%	$116.3M-4.7%	$122.0M-5.9%	$129.7M-9.2%	$142.8M-0.5%	$143.6M-4.1%	$149.7M-3.8%	$155.6M
Current Assets	$112.7M-0.8%	$113.6M-4.9%	$119.4M-5.9%	$126.9M-9.2%	$139.8M-0.5%	$140.5M-4.0%	$146.3M-3.8%	$152.1M
Cash & Equivalents	$92.0M-0.4%	$92.4M-9.0%	$101.5M-6.7%	$108.8M-9.6%	$120.4M+1.5%	$118.6M+0.3%	$118.2M-7.2%	$127.3M
Inventory	$7.8M-2.7%	$8.0M+28.5%	$6.2M+7.0%	$5.8M-8.2%	$6.3M+3.8%	$6.1M-10.2%	$6.8M-1.3%	$6.9M
Accounts Receivable	$9.7M0.0%	$9.7M+1.4%	$9.6M+2.0%	$9.4M-12.6%	$10.8M-16.6%	$12.9M-35.1%	$19.9M+27.3%	$15.6M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$51.4M-1.2%	$52.0M0.0%	$52.0M-0.2%	$52.1M-5.9%	$55.3M+13.7%	$48.6M+1.2%	$48.1M+3.7%	$46.4M
Current Liabilities	$11.0M-6.8%	$11.8M-0.9%	$11.9M-1.5%	$12.1M-21.6%	$15.5M+12.1%	$13.8M+3.8%	$13.3M+13.6%	$11.7M
Long-Term Debt	$40.3M+0.6%	$40.1M+0.6%	$39.8M+0.6%	$39.6M+0.6%	$39.4M+15.2%	$34.2M+1.1%	$33.8M+0.2%	$33.7M
Total Equity	$63.9M-0.5%	$64.3M-8.2%	$70.0M-9.8%	$77.6M-11.3%	$87.5M-7.8%	$95.0M-6.6%	$101.6M-6.9%	$109.2M
Retained Earnings	-$384.7M-1.1%	-$380.6M-2.2%	-$372.4M-3.3%	-$360.5M-4.1%	-$346.3M-3.5%	-$334.5M-3.4%	-$323.4M-4.0%	-$311.1M

SGHT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$29.7M-32.9%	-$22.4M+52.6%	-$47.2M+37.9%	-$76.0M-44.6%	-$52.5M-63.3%	-$32.2M
Capital Expenditures	$224K-41.8%	$385K-51.3%	$791K-18.5%	$970K+19.3%	$813K-14.7%	$953K
Free Cash Flow	-$29.9M-31.6%	-$22.7M+52.6%	-$48.0M+37.6%	-$76.9M-44.2%	-$53.4M-61.1%	-$33.1M
Investing Cash Flow	-$224K+41.8%	-$385K+51.3%	-$791K+18.5%	-$970K-19.3%	-$813K+14.7%	-$953K
Financing Cash Flow	$1.8M-63.9%	$5.0M+349.6%	$1.1M-11.5%	$1.2M-99.5%	$252.5M+244.0%	$73.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$1.8M+79.0%	-$8.7M-15.6%	-$7.5M+35.0%	-$11.6M-235.5%	-$3.5M-1055.5%	$362K+103.8%	-$9.5M+3.2%	-$9.8M
Capital Expenditures	-$156K-191.8%	$170K-19.0%	$210K	$0-100.0%	$137K+168.6%	$51K-36.3%	$80K-31.6%	$117K
Free Cash Flow	-$2.0M+77.7%	-$8.9M-14.7%	-$7.8M+33.2%	-$11.6M-222.7%	-$3.6M-1256.3%	$311K+103.3%	-$9.5M+3.6%	-$9.9M
Investing Cash Flow	$156K+191.8%	-$170K+19.0%	-$210K	$0+100.0%	-$137K-168.6%	-$51K+36.3%	-$80K+31.6%	-$117K
Financing Cash Flow	$1.3M+4960.0%	$25K-94.8%	$485K+2931.3%	$16K-99.7%	$5.4M+6990.8%	$76K-82.8%	$441K+146.8%	-$942K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SGHT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	86.2%+0.7pp	85.5%+0.2pp	85.3%+2.7pp	82.7%+0.3pp	82.4%+15.7pp	66.7%
Operating Margin	-47.9%+15.3pp	-63.3%+7.4pp	-70.7%+47.0pp	-117.7%-12.5pp	-105.2%+11.3pp	-116.5%
Net Margin	-49.7%+14.8pp	-64.5%+4.0pp	-68.5%+52.4pp	-120.9%+7.7pp	-128.6%-3.1pp	-125.5%
Return on Equity	-60.1%-1.2pp	-58.9%-12.6pp	-46.2%+7.7pp	-53.9%-26.7pp	-27.1%	N/A
Return on Assets	-33.3%+2.7pp	-36.1%-2.7pp	-33.3%+7.2pp	-40.5%-18.0pp	-22.5%+25.2pp	-47.6%
Current Ratio	10.22+1.2	9.04-4.3	13.29+1.5	11.77-8.7	20.52+12.9	7.58
Debt-to-Equity	0.63+0.2	0.45+0.2	0.26+0.1	0.21+0.1	0.14+0.5	-0.36
FCF Margin	-38.7%-10.2pp	-28.5%+30.7pp	-59.2%+48.7pp	-107.9%+1.1pp	-109.0%+10.9pp	-119.8%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	87.3%+0.9pp	86.4%+1.6pp	84.8%-1.4pp	86.2%-0.6pp	86.8%+2.9pp	83.9%-2.0pp	85.8%+0.3pp	85.5%
Operating Margin	-18.0%+21.7pp	-39.7%+19.9pp	-59.6%+19.5pp	-79.2%-16.6pp	-62.5%-6.8pp	-55.7%+3.5pp	-59.2%+17.2pp	-76.4%
Net Margin	-20.4%+20.6pp	-41.0%+20.0pp	-61.0%+19.8pp	-80.8%-18.7pp	-62.1%-7.2pp	-54.9%+2.8pp	-57.7%+26.7pp	-84.4%
Return on Equity	-6.5%+6.2pp	-12.7%+4.4pp	-17.1%+1.2pp	-18.2%-4.7pp	-13.5%-1.9pp	-11.7%+0.5pp	-12.1%+2.8pp	-14.9%
Return on Assets	-3.6%+3.4pp	-7.0%+2.8pp	-9.8%+1.1pp	-10.9%-2.6pp	-8.3%-0.6pp	-7.7%+0.5pp	-8.2%+2.2pp	-10.5%
Current Ratio	10.22+0.6	9.60-0.4	10.01-0.5	10.47+1.4	9.04-1.1	10.18-0.8	11.01-2.0	13.01
Debt-to-Equity	0.630.0	0.62+0.1	0.57+0.1	0.51+0.1	0.45+0.1	0.36+0.0	0.33+0.0	0.31
FCF Margin	-9.7%+34.9pp	-44.6%-5.0pp	-39.6%+26.6pp	-66.3%-47.4pp	-18.9%-20.4pp	1.5%+46.2pp	-44.7%+6.7pp	-51.4%

Similar Companies

Cvrx, Inc. CVRX

$239.4M

BioSig Technologies Inc BSGM

$157.0M

Electromed ELMD

$195.7M

Accuray Incorp ARAY

$46.2M

Monogram Orthopaedics Inc MGRM

$243.8M

Frequently Asked Questions

What is Sight Sciences, Inc.'s annual revenue?

Sight Sciences, Inc. (SGHT) reported $77.4M in total revenue for fiscal year 2025. This represents a -3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Sight Sciences, Inc.'s revenue growing?

Sight Sciences, Inc. (SGHT) revenue declined by 3.1% year-over-year, from $79.9M to $77.4M in fiscal year 2025.

Is Sight Sciences, Inc. profitable?

No, Sight Sciences, Inc. (SGHT) reported a net income of -$38.4M in fiscal year 2025, with a net profit margin of -49.7%.

What is Sight Sciences, Inc.'s EBITDA?

Sight Sciences, Inc. (SGHT) had EBITDA of -$36.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Sight Sciences, Inc. have?

As of fiscal year 2025, Sight Sciences, Inc. (SGHT) had $92.0M in cash and equivalents against $40.3M in long-term debt.

What is Sight Sciences, Inc.'s gross margin?

Sight Sciences, Inc. (SGHT) had a gross margin of 86.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Sight Sciences, Inc.'s operating margin?

Sight Sciences, Inc. (SGHT) had an operating margin of -47.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Sight Sciences, Inc.'s net profit margin?

Sight Sciences, Inc. (SGHT) had a net profit margin of -49.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Sight Sciences, Inc.'s return on equity (ROE)?

Sight Sciences, Inc. (SGHT) has a return on equity of -60.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Sight Sciences, Inc.'s free cash flow?

Sight Sciences, Inc. (SGHT) generated -$29.9M in free cash flow during fiscal year 2025. This represents a -31.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Sight Sciences, Inc.'s operating cash flow?

Sight Sciences, Inc. (SGHT) generated -$29.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Sight Sciences, Inc.'s total assets?

Sight Sciences, Inc. (SGHT) had $115.3M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Sight Sciences, Inc.'s capital expenditures?

Sight Sciences, Inc. (SGHT) invested $224K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Sight Sciences, Inc. spend on research and development?

Sight Sciences, Inc. (SGHT) invested $14.6M in research and development during fiscal year 2025.

How many shares does Sight Sciences, Inc. have outstanding?

Sight Sciences, Inc. (SGHT) had 53M shares outstanding as of fiscal year 2025.

What is Sight Sciences, Inc.'s current ratio?

Sight Sciences, Inc. (SGHT) had a current ratio of 10.22 as of fiscal year 2025, which is generally considered healthy.

What is Sight Sciences, Inc.'s debt-to-equity ratio?

Sight Sciences, Inc. (SGHT) had a debt-to-equity ratio of 0.63 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Sight Sciences, Inc.'s return on assets (ROA)?

Sight Sciences, Inc. (SGHT) had a return on assets of -33.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Sight Sciences, Inc.'s cash runway?

Based on fiscal year 2025 data, Sight Sciences, Inc. (SGHT) had $92.0M in cash against an annual operating cash burn of $29.7M. This gives an estimated cash runway of approximately 37 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Sight Sciences, Inc.'s Piotroski F-Score?

Sight Sciences, Inc. (SGHT) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Sight Sciences, Inc.'s earnings high quality?

Sight Sciences, Inc. (SGHT) has an earnings quality ratio of 0.77x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Sight Sciences, Inc. cover its interest payments?

Sight Sciences, Inc. (SGHT) has an interest coverage ratio of -7.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Sight Sciences, Inc.?

Sight Sciences, Inc. (SGHT) scores 36 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.